To study the effect of KANTAKARYAVALEHYA (a drug used in treating Asthma, Bronchitis, Cough) on ECP (a specific protein of Eosinophils involved in Asthma) Levels in Childhood asthma
Not Applicable
Completed
- Conditions
- Health Condition 1: null- CHILDHOOD ASTHMA
- Registration Number
- CTRI/2016/08/007211
- Lead Sponsor
- RGUHS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1.Patients in the age group of 5 to 15 years.
2.Atopics
3.Intermittent, Mild Persistent and Moderate Persistent Asthma.
Exclusion Criteria
1.Patients with Cardiovascular, Renal and other systemic disorders.
2.Patients with other chronic and infective disorders of respiratory system.
3.Primary Complex.
4.Foreign body aspiration.
5.Acute Severe Asthma.
6.Severe Persistent Asthma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of Kantakaryavalehya is already proved in the previous study done by the Principal Investigator. This study intends to look into the effect of the same drug on Asthma specific marker - ECP levels in cases of Childhood asthmaTimepoint: The efficacy of Kantakaryavalehya is already proved in the previous study done by the Principal Investigator. This study intends to look into the effect of the same drug on Asthma specific marker - ECP levels in cases of Childhood asthma
- Secondary Outcome Measures
Name Time Method 1. Being a cost effective treatment modality <br/ ><br>2. Treatment modality with Nil or very minimal side effects <br/ ><br>3. Other add on benefits like increase in appetiteTimepoint: 2 YEARS